Medizinische Universität Graz Austria/Österreich - Forschungsportal - Medical University of Graz
Gewählte Publikation:
SHR Neuro Krebs Kardio Lipid Stoffw Microb
Schneider-Utaka, AK; Hanes, S; Boughton, CK; Hartnell, S; Thabit, H; Mubita, WM; Draxlbauer, K; Poettler, T; Hayes, J; Wilinska, ME; Mader, JK; Narendran, P; Leelarathna, L; Evans, ML; Hovorka, R; Hood, KK.
Patient-reported outcomes for older adults on CamAPS FX closed loop system.
Diabet Med. 2023; 40(9):e15126
Doi: 10.1111/dme.15126
Web of Science
PubMed
FullText
FullText_MUG
- Co-Autor*innen der Med Uni Graz
- Mader Julia
- Pöttler Tina
- Altmetrics:
- Dimensions Citations:
- Plum Analytics:
- Scite (citation analytics):
- Abstract:
- AIMS: Use of the CamAPS FX hybrid closed loop (CL) system is associated with improved time in range and glycated haemoglobin A1c across the age span, but little is known about its effects on patient-reported outcomes (PROs). METHODS: This open-label, randomized, multi-site study compared CamAPS FX to sensor-augmented pump (SAP) in a sample of older adults (≥60 years) with type 1 diabetes (T1D). Thirty-five older adults completed PROs surveys at the start of the study and after each period of 16 weeks using either CL or SAP. At the end of the study, 19 participated in interviews about their experiences with CL. RESULTS: Results examining the 16 weeks of CL use showed that the overall Diabetes Distress Scale score and two subscales (powerlessness and physician distress) improved significantly along with trust on the Glucose Monitoring Satisfaction Survey. User experience interview responses were consistent in noting benefits of 'improved glycaemic control' and 'worrying less about diabetes'. CONCLUSION: In this sample of older adults with T1D who have previously shown glycaemic benefit, there are indicators of improved PROs and subjective user experience benefits.
- Find related publications in this database (using NLM MeSH Indexing)
- Aged - administration & dosage
- Humans - administration & dosage
- Blood Glucose - administration & dosage
- Blood Glucose Self-Monitoring - methods
- Diabetes Mellitus, Type 1 - drug therapy
- Hypoglycemic Agents - therapeutic use
- Insulin - therapeutic use
- Insulin Infusion Systems - administration & dosage
- Treatment Outcome - administration & dosage
- Middle Aged - administration & dosage
- Find related publications in this database (Keywords)
- automated insulin delivery
- closed loop
- patient-reported outcomes
- type 1 diabetes